This inventor holds 4 USPTO granted patents. Top assignee: Pfizer Corporation. Active years: 1993-1997.
Location History:
- Mystic, CT (US) (1993 - 1996)
- Redwood City, CA (US) (1997)
Company Filing History:
Years Active: 1993-1997
Title: The Innovations of Lapyuen H Lam
Introduction
Lapyuen H Lam is a notable inventor based in Mystic, CT (US). He has made significant contributions to the field of microbiology and pharmaceuticals, holding a total of 4 patents. His work primarily focuses on the preparation of various compounds that have important applications in medicine.
Latest Patents
Lapyuen H Lam's latest patents include the "Preparation of 4-deoxy-O-mycaminosyltylonolide" and "Preparation of 4'-deoxy-O-mycaminosyltylonolide." These patents detail a method for producing these compounds by feeding repromicin to a fermentation broth of a strain of the microorganism Streptomyces fradiae (ATCC 31733) under aerobic conditions in an aqueous nutrient medium containing inorganic salts and assimilable sources of carbon and nitrogen. Another significant patent is for "Cultures for production of avermectin aglycones," which involves mutants of Streptomyces avermitilis that lack the ability to produce glycosylated avermectins. This method is crucial for producing natural and non-natural avermectin aglycones that are useful as parasiticides.
Career Highlights
Lapyuen H Lam is currently employed at Pfizer Corporation, where he continues to innovate and develop new pharmaceutical solutions. His work has been instrumental in advancing the understanding and application of microbial fermentation processes in drug development.
Collaborations
Some of his notable coworkers include Hamish A McArthur and Richard G Wax, who have collaborated with him on various projects within the pharmaceutical industry.
Conclusion
Lapyuen H Lam's contributions to the field of microbiology and pharmaceuticals are significant, as evidenced by his patents and ongoing work at Pfizer Corporation. His innovative approaches continue to impact the development of important medical compounds.